The IKK'beta' kinase is a potential therapeutic target in K-Ras-induced lung cancer (2011)
- Autores:
- Autor USP: BASSÈRES, DANIELA SANCHEZ - IQ
- Unidade: IQ
- Assunto: NEOPLASIAS PULMONARES
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título: Resumos
- Nome do evento: Reunião Anual da Federação de Sociedades de Biologia Experimental
-
ABNT
AOKI, M et al. The IKK'beta' kinase is a potential therapeutic target in K-Ras-induced lung cancer. 2011, Anais.. São Paulo: FeSBE, 2011. . Acesso em: 24 nov. 2025. -
APA
Aoki, M., Ebbs, A., Baldwin, A. S., & Bassères, D. S. (2011). The IKK'beta' kinase is a potential therapeutic target in K-Ras-induced lung cancer. In Resumos. São Paulo: FeSBE. -
NLM
Aoki M, Ebbs A, Baldwin AS, Bassères DS. The IKK'beta' kinase is a potential therapeutic target in K-Ras-induced lung cancer. Resumos. 2011 ;[citado 2025 nov. 24 ] -
Vancouver
Aoki M, Ebbs A, Baldwin AS, Bassères DS. The IKK'beta' kinase is a potential therapeutic target in K-Ras-induced lung cancer. Resumos. 2011 ;[citado 2025 nov. 24 ] - FOXO1 inhibition by oncogenic KRAS as an important mechanism promoting lung oncogenesis
- Requirement of the NF-'capa' B subunit p65/RelA for 'capa'-Ras-induced lung tumorigenesis
- Resenha sem título próprio
- Targeting Aurora kinase activity in lung cancer cell driven by oncogenic KRAS impairs lung cancer initiating cell function
- Exploring IKKβ as an anti-angiogenic therapeutic target in KRAS-induced lung cancer
- IKK is a therapeutic target in KRAS-induced lung cancer with disrupted p53 activity
- Aurora kinases: potential therapeutic targets in K-Ras-induced lung cancer
- Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP alpha expression
- Exploring IKKβ kinase as a therapeutic target for KRAS-driven lung tumor initiating cells
- Exploring IKKβ as an anti-metastatic therapeutic target in KRAS-induced lung cancer
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
